Evidence map›Paper›PMID 26564800›Full record

ArticleMolecular biology of the cell2016

Locus-specific gene repositioning in prostate cancer.

Marc Leshner, Michelle Devine, Gregory W Roloff, Lawrence D True, Tom Misteli, Karen J Meaburn

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Understanding the 3D genome: Emerging impacts on human disease.Seminars in cell & developmental biology · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Cajal body function in genome organization and transcriptome diversity.BioEssays : news and reviews in molecular, cellular and developmental biology · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marc LeshnerNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Michelle DevineNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Gregory W RoloffNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Lawrence D TrueDepartment of Pathology, University of Washington, Seattle, WA 98195.
Tom MisteliNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892 mistelit@mail.nih.gov meaburnk@mail.nih.gov.
Karen J MeaburnNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892 mistelit@mail.nih.gov meaburnk@mail.nih.gov.
National Institutes of Health · USUniversity of Washington · US

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI John Kyung Lee · 2002 to 2026
$58.1M
Nuclear Architecture and DiseaseZIABC010309 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MISTELI, THOMAS A · 2009 to 2025
$39.8M
Intramural NIH HHSNCI NIH HHS P50 CA097186NCI NIH HHS P50CA097186
6 · The paper itself

Abstract

Genes occupy preferred spatial positions within interphase cell nuclei. However, positioning patterns are not an innate feature of a locus, and genes can alter their localization in response to physiological and pathological changes. Here we screen the radial positioning patterns of 40 genes in normal, hyperplasic, and malignant human prostate tissues. We find that the overall spatial organization of the genome in prostate tissue is largely conserved among individuals. We identify three genes whose nuclear positions are robustly altered in neoplastic prostate tissues. FLI1 and MMP9 position differently in prostate cancer than in normal tissue and prostate hyperplasia, whereas MMP2 is repositioned in both prostate cancer and hyperplasia. Our data point to locus-specific reorganization of the genome during prostate disease.

Indexed as

Genetic LociChromosome MappingChromosome StructuresGenome, HumanHumansInterphaseMaleMatrix Metalloproteinase 9Prostatic NeoplasmsProto-Oncogene Protein c-fli-1FLI1 protein, humanMatrix Metalloproteinase 9MMP9 protein, humanProto-Oncogene Protein c-fli-1

Identifiers

PMID26564800
PMCPMC4713128
OpenAlexW2189671405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.